January 05, 2021 Atyr’s Covid-19 benefit claims raise questions The group has blamed placebo “overperformance” on a high proportion of less-sick patients.
April 27, 2020 Kevzara's Covid-19 setback shows need for hard evidence As investors continue to jump on small sparks of hope in the pandemic pipeline Sanofi and Regeneron inject a dose of reality.
